Hypertension and cardiovascular risk: General aspects

被引:387
|
作者
Kjeldsen, Sverre E. [1 ]
机构
[1] Univ Oslo Hosp, Dept Cardiol, N-0407 Oslo, Norway
关键词
Blood pressure; Cardiovascular risk; Cerebral stroke; Hypertension; Target organ damage; Renal disease; SYSTOLIC BLOOD-PRESSURE; EUROPEAN-SOCIETY; TASK-FORCE; STROKE; FRAMINGHAM; MORTALITY; SCORE; PREVALENCE; DISEASE; AGE;
D O I
10.1016/j.phrs.2017.11.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension is the strongest or one of the strongest risk factors for almost all different cardiovascular diseases acquired during life, including coronary disease, left ventricular hypertrophy and valvular heart diseases, cardiac arrhythmias including atrial fibrillation, cerebral stroke and renal failure. The continuous relationship between blood pressure and cardiovascular and renal events makes the distinction between high normal blood pressure and hypertension based on arbitrary cut-off values for blood pressures. Overall the prevalence of hypertension in different European countries appears to be around 30-45% of the general population, with a steep increase with ageing. The prevention of cardiovascular disease and treatment recommendations should be related to quantification of total cardiovascular risk which could be estimated from several different models. However the impact of age on risk is so strong that young adults (particularly women) are unlikely to reach high-risk levels even when they have more than one major risk factor and a clear increase in relative risk. Therefore age-adjusted models, models assessing relative risks compared to others of same age and models including thorough assessments of target organ damage and ambulatory 24 h blood pressure are needed together with national models because of the large variations between countries. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 50 条
  • [31] Cardiovascular risk in Mozambique: who should be treated for hypertension?
    Damasceno, Albertino
    Padrao, Patricia
    Silva-Matos, Carla
    Prista, Antonio
    Azevedo, Ana
    Lunet, Nuno
    JOURNAL OF HYPERTENSION, 2013, 31 (12) : 2348 - 2355
  • [32] Multiple Cardiovascular Risk Factors Indicate Cardiovascular Disease in Stage 1 Hypertension
    DeMarzo, Arthur P.
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2019, 26 (02) : 135 - 137
  • [33] Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension
    De Backer, Guy
    Petrella, Robert J.
    Goudev, Assen R.
    Radaideh, Ghazi A.
    Rynkiewicz, Andrzej
    Pathak, Atul
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 (02) : 210 - 215
  • [34] The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China
    Lewington, Sarah
    Lacey, Ben
    Clarke, Robert
    Guo, Yu
    Kong, Xiang Ling
    Yang, Ling
    Chen, Yiping
    Bian, Zheng
    Chen, Junshi
    Meng, Jinhuai
    Xiong, Youping
    He, Tianyou
    Pang, Zengchang
    Zhang, Shuo
    Collins, Rory
    Peto, Richard
    Li, Liming
    Chen, Zhengming
    JAMA INTERNAL MEDICINE, 2016, 176 (04) : 524 - 532
  • [35] Associations of cardiovascular risk factors with prehypertension and hypertension in women
    Shimomura, Tomoko
    Wakabayashi, Ichiro
    BLOOD PRESSURE, 2012, 21 (06) : 345 - 351
  • [36] Long-Term Cardiovascular Risk Associated With Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline
    Qi, Yue
    Han, Xueyu
    Zhao, Dong
    Wang, Wei
    Wang, Miao
    Sun, Jiayi
    Liu, Jun
    Li, Yan
    Gao, Shen
    Hao, Yongchen
    Deng, Qiuju
    Liu, Jing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (11) : 1201 - 1210
  • [37] Cardiovascular risk and cardiovascular risk factors in adolescents
    Chaves Rouberte, Emilia Soares
    de Araujo, Thelma Leite
    de Sousa, Daniel Freire
    Castro Nogueira, Daiany Maria
    Maia, Rebecca Silveira
    Moreira, Rafaella Pessoa
    Holanda de Sousa, Ederson Laurindo
    Bezerra Pinto, Livia Mara
    REVISTA BRASILEIRA DE ENFERMAGEM, 2022, 75 (04)
  • [38] Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study
    Imai, Yukiko
    Hirata, Takumi
    Saitoh, Shigeyuki
    Ninomiya, Toshiharu
    Miyamoto, Yoshihiro
    Ohnishi, Hirofumi
    Murakami, Yoshitaka
    Iso, Hiroyasu
    Tanaka, Sachiko
    Miura, Katsuyuki
    Tamakoshi, Akiko
    Yamada, Michiko
    Kiyama, Masahiko
    Ueshima, Hirotsugu
    Ishikawa, Shizukiyo
    Okamura, Tomonori
    HYPERTENSION RESEARCH, 2020, 43 (12) : 1437 - 1444
  • [39] Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events?
    Nanna, Michael G.
    Navar, Ann Marie
    Wojdyla, Daniel
    Nelson, Adam J.
    Sullivan, Alex E.
    Peterson, Eric D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 142 : 83 - 90
  • [40] Silent brain infarcts, peripheral vascular disease and the risk of cardiovascular events in patients with hypertension
    Jimenez-Balado, Joan
    Riba-Llena, Iolanda
    Nafria, Cristina
    Pizarro, Jesus
    Rodriguez-Luna, David
    Maisterra, Olga
    Ballve, Alejandro
    Mundet, Xavier
    Violan, Concepcion
    Ventura, Oriol
    Montaner, Joan
    Delgado, Pilar
    JOURNAL OF HYPERTENSION, 2022, 40 (08) : 1469 - 1477